Finance

Lists
003220:KRX
Daewon Pharmaceutical Co Ltd
8 000,00 KRW
+1,52%
(+120,00) 1D
19-окт., 15:30:28 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003220...
Open
7 720 KRW
High
8 000 KRW
Low
7 720 KRW
Mkt. cap
179,42 млд
Avg. vol.
49,23 миң
Volume
20,17 миң
Dividend
3,12%
Quarterly dividend
62 KRW
Ex-dividend date
2025-ж., 29-дек.
P/E ratio
68,28
52-wk high
13 670 KRW
52-wk low
7 060 KRW
EPS
117 KRW
Shares outstanding
22,43 млн
No. of employees
1 миң
Open
7 720 KRW
High
8 000 KRW
Low
7 720 KRW
Mkt. cap
179,42 млд
Avg. vol.
49,23 миң
Volume
20,17 миң
Dividend
3,12%
Quarterly dividend
62 KRW
Ex-dividend date
2025-ж., 29-дек.
P/E ratio
68,28
52-wk high
13 670 KRW
52-wk low
7 060 KRW
EPS
117 KRW
Shares outstanding
22,43 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Daewon Pharmaceutical Co Ltd
CEOJonathan In Baek | Baek Seung-yeol
Employees1,24 миң
Founded1958
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
143,94 млд
159,81 млд
158,06 млд
152,83 млд
Cost of goods sold
83,20 млд
86,55 млд
83,32 млд
82,01 млд
Cost of revenue
83,20 млд
86,55 млд
83,32 млд
82,01 млд
Research and development expenses
6,44 млд
6,55 млд
6,78 млд
4,84 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,82 млд
58,27 млд
60,97 млд
63,81 млд
Operating expense
71,13 млд
67,39 млд
70,35 млд
70,77 млд
Total operating expenses
154,33 млд
153,93 млд
153,67 млд
152,79 млд
Operating income
-10,39 млд
5,88 млд
4,38 млд
43,44 млн
Other non operating income
-1,24 млд
-2,49 млд
127,02 млн
2,35 млд
EBT including unusual items
-12,01 млд
11,79 млд
3,92 млд
5,35 млд
EBT excluding unusual items
-11,95 млд
2,77 млд
4,15 млд
3,31 млд
Income tax expense
6,02 млд
-2,45 млд
1,83 млд
1,35 млд
Effective tax rate
-50,14%
-20,77%
46,72%
25,25%
Other operating expenses
890,07 млн
847,43 млн
869,07 млн
818,26 млн
Net income
-17,41 млд
13,60 млд
2,42 млд
4,03 млд
Net profit margin
-12,10%
8,51%
1,53%
2,64%
Earnings per share
-
-
-
-
Interest and investment income
150,63 млн
346,40 млн
449,07 млн
307,63 млн
Interest expense
-1,98 млд
-1,40 млд
-1,74 млд
-1,65 млд
Net interest expenses
-1,82 млд
-1,06 млд
-1,29 млд
-1,34 млд
Depreciation and amortization charges
1,15 млд
1,06 млд
1,05 млд
1,08 млд
EBITDA
-4,51 млд
11,94 млд
10,76 млд
6,31 млд
Gain or loss from assets sale
-197,23 млн
1,85 млд
4,90 млн
-1,76 млд
AI content may include mistakes. Learn more
Google колдонмолору